174 related articles for article (PubMed ID: 38338850)
1. Prognostic Impact of Heat Shock Protein 90 Expression in Women Diagnosed with Cervical Cancer.
Vogelsang TLR; Schmoeckel E; Topalov NE; Ganster F; Mahner S; Jeschke U; Vattai A
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338850
[TBL] [Abstract][Full Text] [Related]
2. Expression of heat-shock protein Hsp60 correlated with the apoptotic index and patient prognosis in human oesophageal squamous cell carcinoma.
Faried A; Sohda M; Nakajima M; Miyazaki T; Kato H; Kuwano H
Eur J Cancer; 2004 Dec; 40(18):2804-11. PubMed ID: 15571964
[TBL] [Abstract][Full Text] [Related]
3. Elevated expression of iASPP correlates with poor prognosis and chemoresistance/radioresistance in FIGO Ib1-IIa squamous cell cervical cancer.
Cao L; Huang Q; He J; Lu J; Xiong Y
Cell Tissue Res; 2013 May; 352(2):361-9. PubMed ID: 23420450
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of long non-coding RNA CCAT2 correlates with tumor metastasis and poor prognosis in cervical squamous cell cancer patients.
Chen X; Liu L; Zhu W
Int J Clin Exp Pathol; 2015; 8(10):13261-6. PubMed ID: 26722527
[TBL] [Abstract][Full Text] [Related]
5. Suppression of heat shock protein 27 using OGX-427 induces endoplasmic reticulum stress and potentiates heat shock protein 90 inhibitors to delay castrate-resistant prostate cancer.
Lamoureux F; Thomas C; Yin MJ; Fazli L; Zoubeidi A; Gleave ME
Eur Urol; 2014 Jul; 66(1):145-55. PubMed ID: 24411988
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of Hsp90 inhibition for induction of apoptosis and inhibition of growth in cervical carcinoma cells in vitro and in vivo.
Schwock J; Pham NA; Cao MP; Hedley DW
Cancer Chemother Pharmacol; 2008 Apr; 61(4):669-81. PubMed ID: 17579866
[TBL] [Abstract][Full Text] [Related]
7. Heat shock protein 90 is a putative therapeutic target in patients with recurrent advanced-stage ovarian carcinoma with serous effusions.
Elstrand MB; Stavnes HT; Tropé CG; Davidson B
Hum Pathol; 2012 Apr; 43(4):529-35. PubMed ID: 21864883
[TBL] [Abstract][Full Text] [Related]
8. Heat shock protein 90 as a molecular target for therapy in oral squamous cell carcinoma: Inhibitory effects of 17‑DMAG and ganetespib on tumor cells.
Shiraishi N; Onda T; Hayashi K; Onidani K; Watanabe K; Sekikawa S; Shibahara T
Oncol Rep; 2021 Feb; 45(2):448-458. PubMed ID: 33416122
[TBL] [Abstract][Full Text] [Related]
9. Targeting focal adhesion kinase with dominant-negative FRNK or Hsp90 inhibitor 17-DMAG suppresses tumor growth and metastasis of SiHa cervical xenografts.
Schwock J; Dhani N; Cao MP; Zheng J; Clarkson R; Radulovich N; Navab R; Horn LC; Hedley DW
Cancer Res; 2009 Jun; 69(11):4750-9. PubMed ID: 19458065
[TBL] [Abstract][Full Text] [Related]
10. Interplay between the Hsp90 Chaperone and the HslVU Protease To Regulate the Level of an Essential Protein in Shewanella oneidensis.
Honoré FA; Maillot NJ; Méjean V; Genest O
mBio; 2019 May; 10(3):. PubMed ID: 31088919
[TBL] [Abstract][Full Text] [Related]
11. Hsp90 is expressed and represents a therapeutic target in human oesophageal cancer using the inhibitor 17-allylamino-17-demethoxygeldanamycin.
Wu X; Wanders A; Wardega P; Tinge B; Gedda L; Bergstrom S; Sooman L; Gullbo J; Bergqvist M; Hesselius P; Lennartsson J; Ekman S
Br J Cancer; 2009 Jan; 100(2):334-43. PubMed ID: 19142186
[TBL] [Abstract][Full Text] [Related]
12. The Hsp70-Hsp90 Chaperone Cascade in Protein Folding.
Morán Luengo T; Mayer MP; Rüdiger SGD
Trends Cell Biol; 2019 Feb; 29(2):164-177. PubMed ID: 30502916
[TBL] [Abstract][Full Text] [Related]
13. [Outcomes and prognosis of radical surgery in patients with stageⅠb2 and Ⅱa2 cervical squamous cell carcinoma].
Zhou F; Chen F; Pan T; Zhu T; Zhang YL; Zhang P; Tang HR
Zhonghua Fu Chan Ke Za Zhi; 2022 May; 57(5):361-369. PubMed ID: 35658327
[No Abstract] [Full Text] [Related]
14. Expression of heat-shock proteins hsp27, hsp70 and hsp90 in malignant epithelial tumour of the ovaries.
Elpek GO; Karaveli S; Simşek T; Keles N; Aksoy NH
APMIS; 2003 Apr; 111(4):523-30. PubMed ID: 12780528
[TBL] [Abstract][Full Text] [Related]
15. Special AT-rich sequence-binding protein 1: a novel biomarker predicting cervical squamous cell carcinoma prognosis and lymph node metastasis.
Wang S; Wang L; Zhang Y; Liu Y; Meng F; Ma J; Shang P; Gao Y; Huang Q; Chen X
Jpn J Clin Oncol; 2015 Sep; 45(9):812-8. PubMed ID: 26117495
[TBL] [Abstract][Full Text] [Related]
16. Docosahexaenoic Acid-mediated Inhibition of Heat Shock Protein 90-p23 Chaperone Complex and Downstream Client Proteins in Lung and Breast Cancer.
Mouradian M; Ma IV; Vicente ED; Kikawa KD; Pardini RS
Nutr Cancer; 2017 Jan; 69(1):92-104. PubMed ID: 27880046
[TBL] [Abstract][Full Text] [Related]
17. Expression of Beclin 1 and LC3 in FIGO stage I-II cervical squamous cell carcinoma and relationship to survival.
Zhu W; Pan X; Li F; Zhang Y; Lu X
Tumour Biol; 2012 Oct; 33(5):1653-9. PubMed ID: 22648564
[TBL] [Abstract][Full Text] [Related]
18. Heat shock protein 90 (HSP90) is overexpressed in p16-negative oropharyngeal squamous cell carcinoma, and its inhibition in vitro potentiates the effects of chemoradiation.
Patel K; Wen J; Magliocca K; Muller S; Liu Y; Chen ZG; Saba N; Diaz R
Cancer Chemother Pharmacol; 2014 Nov; 74(5):1015-22. PubMed ID: 25205430
[TBL] [Abstract][Full Text] [Related]
19. HSP70-HSP90 Chaperone Networking in Protein-Misfolding Disease.
Prodromou C; Aran-Guiu X; Oberoi J; Perna L; Chapple JP; van der Spuy J
Subcell Biochem; 2023; 101():389-425. PubMed ID: 36520314
[TBL] [Abstract][Full Text] [Related]
20. Cervical Cancer in Women Aged 35 Years and Younger.
Pelkofski E; Stine J; Wages NA; Gehrig PA; Kim KH; Cantrell LA
Clin Ther; 2016 Mar; 38(3):459-66. PubMed ID: 26899314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
